[Anaphylaxis and anaphylactic shock].

Abstract

The anaphylactic shock is an acute, multisystemic and potentially fatal circulatory insufficiency, secondary to an allergic reaction. The prevalence of anaphylaxis is underestimated in the general population. Many studies have reported a prevalence of 0.05-2%. Multiple etiologies are incriminated in the pathogenesis of anaphylaxis, and these etiologies vary depending on age and geographic zones. The clinical manifestations of anaphylaxis are multiple, owing to the multisystemic character of this pathology. The gold standard in management of anaphylaxis is thought to be the rapid and early administration of epinephrine by intra-muscular route. The prevention of anaphylaxis remains the treatment of choice. Educating the patient is an important aspect of anaphylaxis follow-up along with the prescription of epinephrine autoinjectors.

• Authors: Muriel Abi Khalil, Hassen Damak, Dumeng Décosterd
• Journal: Revue medicale suisse (Rev Med Suisse) Vol. 10 Issue 438 Pg. 1511-5 (Aug 13 2014) ISSN: 1660-9379 [Print] Switzerland
• Vernacular Title: Anaphylaxie et etat de choc anaphylactique.
• PMID: 25199227 (Publication Type: English Abstract, Journal Article)

Chemical References

• Bronchodilator Agents
• Glucocorticoids
• Epinephrine

Topics

• Algorithms
• Anaphylaxis (diagnosis, therapy)
• Bronchodilator Agents (therapeutic use)
• Diagnosis, Differential
• Epinephrine (therapeutic use)
• Glucocorticoids (therapeutic use)
• Humans
• Risk Factors